Davenport & Co’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.93M | Buy |
5,851
+447
| +8% | +$215K | 0.01% | 488 |
|
|
2026
Q1 | $2.66M | Buy |
5,404
+334
| +7% | +$181K | 0.01% | 464 |
|
|
2025
Q4 | $2.94M | Sell |
5,070
-34,817
| -87% | -$19.7M | 0.02% | 444 |
|
|
2025
Q3 | $19.3M | Buy |
39,887
+34,839
| +690% | +$16.2M | 0.1% | 166 |
|
|
2025
Q2 | $2.05M | Buy |
5,048
+380
| +8% | +$159K | 0.01% | 509 |
|
|
2025
Q1 | $2.32M | Buy |
4,668
+562
| +14% | +$304K | 0.01% | 454 |
|
|
2024
Q4 | $2.14M | Sell |
4,106
-76
| -2% | -$41.8K | 0.01% | 466 |
|
|
2024
Q3 | $2.59M | Sell |
4,182
-1
| -0% | -$592 | 0.01% | 421 |
|
|
2024
Q2 | $2.31M | Sell |
4,183
-81
| -2% | -$46.4K | 0.01% | 426 |
|
|
2024
Q1 | $2.48M | Buy |
4,264
+83
| +2% | +$46.6K | 0.02% | 397 |
|
|
2023
Q4 | $2.22M | Buy |
4,181
+202
| +5% | +$97.8K | 0.02% | 394 |
|
|
2023
Q3 | $2.01M | Sell |
3,979
-92
| -2% | -$49K | 0.02% | 377 |
|
|
2023
Q2 | $2.12M | Sell |
4,071
-172
| -4% | -$92.8K | 0.02% | 376 |
|
|
2023
Q1 | $2.45M | Buy |
4,243
+8
| +0.2% | +$4.51K | 0.02% | 352 |
|
|
2022
Q4 | $2.33M | Buy |
4,235
+124
| +3% | +$65.7K | 0.02% | 348 |
|
|
2022
Q3 | $2.08M | Sell |
4,111
-193
| -4% | -$108K | 0.02% | 347 |
|
|
2022
Q2 | $2.34M | Sell |
4,304
-81
| -2% | -$44.6K | 0.02% | 341 |
|
|
2022
Q1 | $2.59M | Buy |
4,385
+76
| +2% | +$43.7K | 0.02% | 356 |
|
|
2021
Q4 | $2.88M | Buy |
4,309
+134
| +3% | +$83.7K | 0.02% | 345 |
|
|
2021
Q3 | $2.38M | Buy |
4,175
+270
| +7% | +$148K | 0.02% | 355 |
|
|
2021
Q2 | $1.97M | Buy |
3,905
+605
| +18% | +$285K | 0.02% | 336 |
|
|
2021
Q1 | $1.51M | Buy |
3,300
+118
| +4% | +$56.3K | 0.01% | 326 |
|
|
2020
Q4 | $1.48M | Buy |
3,182
+262
| +9% | +$123K | 0.01% | 318 |
|
|
2020
Q3 | $1.29M | Buy |
2,920
+137
| +5% | +$56.6K | 0.01% | 302 |
|
|
2020
Q2 | $1.01M | Sell |
2,783
-152
| -5% | -$50.9K | 0.01% | 330 |
|
|
2020
Q1 | $832K | Buy |
2,935
+243
| +9% | +$76.6K | 0.01% | 325 |
|
|
2019
Q4 | $875K | Buy |
2,692
+154
| +6% | +$46.7K | 0.01% | 364 |
|
|
2019
Q3 | $745K | Hold |
2,538
| – | – | 0.01% | 378 |
|
|
2019
Q2 | $745K | Buy |
2,538
+343
| +16% | +$94.5K | 0.01% | 377 |
|
|
2019
Q1 | $601K | Buy |
2,195
+105
| +5% | +$26.1K | 0.01% | 388 |
|
|
2018
Q4 | $468K | Buy |
2,090
+383
| +22% | +$89.9K | 0.01% | 411 |
|
|
2018
Q3 | $417K | Buy |
1,707
+25
| +1% | +$5.75K | ﹤0.01% | 480 |
|
|
2018
Q2 | $348K | Buy |
1,682
+274
| +19% | +$58.2K | ﹤0.01% | 527 |
|
|
2018
Q1 | $291K | Buy |
1,408
+100
| +8% | +$21K | ﹤0.01% | 559 |
|
|
2017
Q4 | $248K | Sell |
1,308
-58
| -4% | -$11.1K | ﹤0.01% | 603 |
|
|
2017
Q3 | $258K | Sell |
1,366
-77
| -5% | -$13.9K | ﹤0.01% | 575 |
|
|
2017
Q2 | $252K | Buy |
+1,443
| New | +$242K | ﹤0.01% | 573 |
|
Other funds holding TMO
RG
LT
ATO
CF
Davenport & Co's TMO Position: Q2 2026 in Review
Davenport & Co increased its Thermo Fisher Scientific (TMO) stake by 8.3% in Q2 2026, buying an estimated $215K and bringing the position to 5,851 shares worth $2.93M. The position accounts for 0.01% of the portfolio, ranked #488.
Davenport & Co first reported a position in TMO in Q2 2017 and has held it in 37 quarters since. The position peaked at $19.3M in Q3 2025. 678 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Davenport & Co held 5,851 shares of Thermo Fisher Scientific worth $2.93M as of Q2 2026.
- Davenport & Co bought 447 Thermo Fisher Scientific shares in Q2 2026, an estimated $215K.
- Thermo Fisher Scientific made up 0.01% of Davenport & Co's portfolio in Q2 2026, its #488 holding.
- Davenport & Co first reported a position in Thermo Fisher Scientific in Q2 2017 and has held it in 37 quarters since.
- Davenport & Co's Thermo Fisher Scientific position peaked at $19.3M in Q3 2025.
- 678 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.